Your browser doesn't support javascript.
loading
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial.
Szarek, Michael; White, Harvey D; Schwartz, Gregory G; Alings, Marco; Bhatt, Deepak L; Bittner, Vera A; Chiang, Chern-En; Diaz, Rafael; Edelberg, Jay M; Goodman, Shaun G; Hanotin, Corinne; Harrington, Robert A; Jukema, J Wouter; Kimura, Takeshi; Kiss, Robert Gabor; Lecorps, Guillaume; Mahaffey, Kenneth W; Moryusef, Angèle; Pordy, Robert; Roe, Matthew T; Tricoci, Pierluigi; Xavier, Denis; Zeiher, Andreas M; Steg, Ph Gabriel.
Afiliación
  • Szarek M; State University of New York, Downstate School of Public Health, Brooklyn, New York. Electronic address: michael.szarek@downstate.edu.
  • White HD; University of Auckland and Green Lane Cardiovascular Services Auckland City Hospital, Auckland, New Zealand.
  • Schwartz GG; Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.
  • Alings M; Amphia Ziekenhuis Molengracht, Breda, the Netherlands.
  • Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts. Electronic address: https://twitter.com/DLBHATTMD.
  • Bittner VA; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
  • Chiang CE; General Clinical Research Center, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan.
  • Diaz R; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina.
  • Edelberg JM; Sanofi, Bridgewater, New Jersey.
  • Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, and St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Hanotin C; Sanofi, Paris, France.
  • Harrington RA; Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, California.
  • Jukema JW; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Kimura T; Kyoto University Graduate School of Medicine, Kyoto-shi, Kyoto, Japan.
  • Kiss RG; Magyar Honvédség Egészségügyi Központ, Budapest, Hungary.
  • Lecorps G; Sanofi, Paris, France.
  • Mahaffey KW; Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, California.
  • Moryusef A; Sanofi, Bridgewater, New Jersey.
  • Pordy R; Regeneron Pharmaceuticals Inc., Tarrytown, New York.
  • Roe MT; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
  • Tricoci P; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
  • Xavier D; Department of Pharmacology and Division of Clinical Research, St. John's Medical College and Research Institute, Bangalore, India.
  • Zeiher AM; Department of Medicine III, Goethe University, Frankfurt am Main, Germany.
  • Steg PG; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris and Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), INSERM U1148, Paris, France; National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, United Kingdom. Electro
J Am Coll Cardiol ; 73(4): 387-396, 2019 02 05.
Article en En | MEDLINE | ID: mdl-30428396
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_ischemic_heart_disease Asunto principal: Síndrome Coronario Agudo / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_ischemic_heart_disease Asunto principal: Síndrome Coronario Agudo / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Año: 2019 Tipo del documento: Article